CN109170893A - 用于高血压症的食疗营养素固体饮料及其制备方法 - Google Patents
用于高血压症的食疗营养素固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN109170893A CN109170893A CN201811149052.XA CN201811149052A CN109170893A CN 109170893 A CN109170893 A CN 109170893A CN 201811149052 A CN201811149052 A CN 201811149052A CN 109170893 A CN109170893 A CN 109170893A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- powder
- solid beverage
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 26
- 239000007787 solid Substances 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims abstract description 19
- 235000005911 diet Nutrition 0.000 title claims abstract description 18
- 230000002792 vascular Effects 0.000 title claims abstract description 17
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 16
- 230000037213 diet Effects 0.000 title claims abstract description 15
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 23
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- 235000019441 ethanol Nutrition 0.000 claims abstract description 14
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 239000000047 product Substances 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 11
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004375 Dextrin Substances 0.000 claims abstract description 5
- 229920001353 Dextrin Polymers 0.000 claims abstract description 5
- 235000019425 dextrin Nutrition 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 4
- 241000018646 Pinus brutia Species 0.000 claims abstract description 4
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- 238000005325 percolation Methods 0.000 claims abstract description 4
- 238000007873 sieving Methods 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 241000723353 Chrysanthemum Species 0.000 claims description 11
- 235000010599 Verbascum thapsus Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000006837 decompression Effects 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000001631 hypertensive effect Effects 0.000 description 5
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 208000027796 Blood pressure disease Diseases 0.000 description 1
- SBVZTBIAKFTNIJ-CZNQJBLBSA-N Cassiaside Chemical compound C1=CC=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SBVZTBIAKFTNIJ-CZNQJBLBSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- OXLQCHMJDJSJKF-UHFFFAOYSA-N cassiaside Natural products C1=C(O)C=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1OC1OC(CO)C(O)C(O)C1O OXLQCHMJDJSJKF-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960003580 felodipine Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000010010 raising Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供了一种用于高血压症的食疗营养素固体饮料及其制备方法。固体饮料有效成分为桑叶2.0～2.5重量份、菊花1.0～1.5重量份、决明子1.0～1.5重量份、葛根1.0～1.5重量份和山楂1.5～2.0重量份。制作方法：取决明子、葛根、山楂三味中药，按比例混合，打成粗粉，过10目筛，加入三味中药总重量10倍量的水，煎煮，提取两次，每次提取待沸腾后保持30分钟，合并滤液，低温浓缩至稠膏，减压干燥，得干膏，打粉，得提取物粉末1；取桑叶、菊花两味中药，按比例混合，加乙醇，低温萃取4小时，40倍量乙醇渗漉，渗漉液减压回收乙醇至干，得干膏，打粉，得提取物粉末2。将上述提取物粉末1及提取物粉末2按照1：1比例，与一定量糊精混匀，过筛，装袋得成品。
Description
技术领域
本发明涉及一种用于高血压症的食疗营养素固体饮料及其制备方法，属于食疗营养素固体饮料及其制备方法技术领域。
背景技术
现有的食疗产品主要采用药食兼备的原材料，针对某些疾病参与治疗，该食疗产品针对的是疾病本身，所以配方庞杂，加工工艺繁琐。其食疗产品的有效性有待进一步论证。对于维生素及微量元素营养组分，选取食品级别优质原料。对于发挥核心调节功能的中药组分，采用多种工艺，旨在最大程度保证药物疗效。在中药组分提取过程中，根据每种药味的不同性质，采用不同的提取方法。对于质地坚硬，有效成分稳定、难以提取的中药材，采用高温煎煮方法进行提取；对于质地轻、受热成分易变化的中药材，采用低温萃取渗漉方法，最大程度的保留了中药的活性药效组分。发挥疗效，该技术的复合应用，根据原物料之特性与产品需求进行组合调整，具有高效率、环保、安全与确保有效成分活性等优点，适用范围广泛。在低温萃取中，操作温度低于60℃，可确保天然物中有效成分的活性，并快速高效去除溶剂，以经济、高效的方式进行萃取分离，可充分保留其热不稳定有效成分与药材固有的芳香气味。
发明内容
本发明的目的是为了解决上述现有技术存在的问题，进而提供一种用于高血压症的食疗营养素固体饮料及其制备方法。
本发明的目的是通过以下技术方案实现的：
一种用于高血压症的食疗营养素固体饮料，其有效成分为桑叶2.0～2.5重量份、菊花1.0～1.5重量份、决明子1.0～1.5重量份、葛根1.0～1.5重量份和山楂1.5～2.0重量份。
用于高血压症的食疗营养素固体饮料的制作方法为：取决明子、葛根、山楂三味中药，按比例混合，打成粗粉，过10目筛，加入三味中药总重量10倍量的水，煎煮，提取两次，每次提取待沸腾后保持30分钟，合并滤液，低温浓缩至稠膏，减压干燥，得干膏，打粉，得提取物粉末1；取桑叶、菊花两味中药，按比例混合，加乙醇，低温萃取4小时，40倍量乙醇渗漉，渗漉液减压回收乙醇至干，得干膏，打粉，得提取物粉末2。将上述提取物粉末1及提取物粉末2按照1：1比例，与一定量糊精(辅料)混匀，过筛，装袋(5g一袋)即得成品。
中医认为，外邪久而不解，或饮食劳倦，或情志内伤，导致肝郁气滞，郁而化火，肝阳上亢，风阳上扰，出现头痛、头晕等血压升高之象，治疗当清平肝木，兼以祛风活血。本发明中，桑叶，具有清热散风、降压明目之功效；菊花，味辛、甘、苦，性微寒，归肺、肝经，能疏散风热、平肝明目、清热解毒；决明子，归肝、大肠经，具有清肝泻火，明目，润肠通便之功效；葛根，味甘、辛，性凉，归脾、胃经，具有祛风解肌、生津止渴、升阳透疹、解酒毒之功效；山楂，性微温，味酸、甘，归脾、胃、肝经。功效消食健胃、活血化瘀。两者可解酒食气滞，也可祛风活血，加强君臣清热平肝，祛风散结，活血化瘀之作用。全方配伍，能清平肝木，祛风、化瘀，现代研究表明，配方中药物均有很好降血压作用。本发明对于高血压偏于肝阳上扰者尤为适宜。
桑叶具有清热散风、降压明目之功效，对高血压患者具有良好的降压、保健作用。桑叶中的有效成分主要是黄酮类、生物碱类等化学成分，桑叶中的芦丁、芸香苷、槲皮素能增加心的收缩力与输出量，并减少心率具有明显的扩冠作用，有降血压作用；芸香苷使蟾蜍下肢及兔耳血管收缩，槲皮素可扩张冠状血管，改善心肌循环。
菊花：菊花有清肝明目的作用，对肝阳上亢型高血压有一定的治疗作用。研究表明怀菊花总黄酮对自发性高血压大鼠(SHR)的降压作用及其机制。其降压机制可能与改善内皮功能和抑制肾素～血管紧张素～醛固酮系统(RAAS)活性有关。
决明子：味甘苦咸酸寒,归肝、大肠经,本品成分决明素、决明苷、决明酮有降低血清胆固醇与降血压之功效,对防治血管硬化病、血压病有一定疗效。临床观察决明子降压平稳有效,长期服用无明显不良反应。
葛根：研究显示葛根素联合非洛地平治疗老年高血压病耐受性好，降压作用平稳，总有效率高达90.8％，其降压的机制可能与其可改善内皮细胞结构和功能有关。
山楂：临床曾探讨高血压病患者血浆同型半胱氨酸的含量及中药山楂的干预作用，对36例高血压病患者治疗前后的血浆同型半胱氨酸含量进行检测，并以36例体检正常者作为对照组。结果显示，中药山楂干预前、后血浆同型半胱氨酸含量间差别有非常显著性意义(P<0.01)，表明山楂可降低高血压病患者的血浆同型半胱氨酸的含量。
食用方法：将一袋本发明的固体饮料投入到200～350ml温水中溶解饮用。也可放入粥、汤等食物中食用。每天两次，每次一袋。
食疗观察：选有高血压症者30人(收缩压均在150～180毫米汞柱之间)，其中男18人，女12人，平均年龄58.6岁。食用3个月后(期间不服降压药)，有23人血压降低了15～35毫米汞柱，其余7人降幅很小。本产品可明显改善高血压患者的体质量、腰围、臀围、体脂肪量和体脂肪率。研究表明，高血压患者糖代谢水平对静息能量消耗有影响,需要重视血糖管理，本处方可系统改善血生化指标血糖、血脂和血清尿酸水平；同时，本产品改善降低高血压患者静息能量消耗水平，尤其是对于男性高血压患者及肥胖高血压患者，可明显降低静息能量消耗水平。说明本发明的用于高血压症的食疗营养素固体饮料，对大部分高血压症人群有一定的效果。
本发明的固体饮料不同于保健食品及同类食疗产品，本发明的固体饮料食用后不是直接针对疾病，而主要是对由疾病引起的相关症状群体起到补充缺失营养成分的作用，故使血压趋于正常。方法中采用水提结合低温萃取醇提工艺，保证有效成分溶出，且活性不被破坏。采用粉末形式，体积小、易服用，便于携带。
具体实施方式
下面将对本发明做进一步的详细说明：本实施例在以本发明技术方案为前提下进行实施，给出了详细的实施方式，但本发明的保护范围不限于下述实施例。
实施例1
本实施例所涉及的一种用于高血压症的食疗营养素固体饮料，其有效成分为2.0～2.5重量份、菊花1.0～1.5重量份、决明子1.0～1.5重量份、葛根1.0～1.5重量份和山楂1.5～2.0重量份。
制作方法为：取决明子、葛根、山楂三味中药，按处方比例混合，打成粗粉，过10目筛，加入三味中药总重量10倍量的水，煎煮，提取两次，每次提取待沸腾后保持30分钟，合并滤液，低温浓缩至稠膏，减压干燥，得干膏，打粉，得提取物粉末1；取桑叶、菊花两味中药，按比例混合，加乙醇，低温萃取4小时，40倍量乙醇渗漉，渗漉液减压回收乙醇至干，得干膏，打粉，得提取物粉末2。将上述提取物粉末1及提取物粉末2按照1：1比例(重量比)，与一定量糊精(辅料)混匀，过筛，装袋得成品。
糊精占提取物粉末1和提取物粉末2总重量的10～35％。
实施例2
本实施例所涉及的一种用于高血压症的食疗营养素固体饮料，其有效成分为桑叶2.2重量份、菊花1.3重量份、决明子1.2重量份、葛根1.3重量份和山楂1.8重量份。其它与实施例1相同。
以上所述，仅为本发明较佳的具体实施方式，这些具体实施方式都是基于本发明整体构思下的不同实现方式，而且本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明揭露的技术范围内，可轻易想到的变化或替换，都应涵盖在本发明的保护范围之内。因此，本发明的保护范围应该以权利要求书的保护范围为准。
Claims (4)
1.一种用于高血压症的食疗营养素固体饮料，其特征在于，有效成分为桑叶2.0～2.5重量份、菊花1.0～1.5重量份、决明子1.0～1.5重量份、葛根1.0～1.5重量份和山楂1.5～2.0重量份。
2.根据权利要求1所述的用于高血压症的食疗营养素固体饮料，其特征在于，有效成分为桑叶2.2重量份、菊花1.3重量份、决明子1.2重量份、葛根1.3重量份和山楂1.8重量份。
3.一种权利要求1所述的用于高血压症的食疗营养素固体饮料的制备方法，其特征在于，取决明子、葛根和山楂三味中药，按比例混合，打成粗粉，过10目筛，加入三味中药总重量10倍量的水，煎煮，提取两次，每次提取待沸腾后保持30分钟，合并滤液，低温浓缩至稠膏，减压干燥，得干膏，打粉，得提取物粉末1；取桑叶、菊花两味中药，按比例混合，加乙醇，低温萃取4小时，40倍量乙醇渗漉，渗漉液减压回收乙醇至干，得干膏，打粉，得提取物粉末2，将上述提取物粉末1及提取物粉末2按照1：1比例，与糊精混匀，过筛，装袋得成品。
4.根据权利要求3所述的用于高血压症的食疗营养素固体饮料的制备方法，其特征在于，糊精占提取物粉末1和提取物粉末2总重量的10～35％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811149052.XA CN109170893A (zh) | 2018-09-29 | 2018-09-29 | 用于高血压症的食疗营养素固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811149052.XA CN109170893A (zh) | 2018-09-29 | 2018-09-29 | 用于高血压症的食疗营养素固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109170893A true CN109170893A (zh) | 2019-01-11 |
Family
ID=64907854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811149052.XA Pending CN109170893A (zh) | 2018-09-29 | 2018-09-29 | 用于高血压症的食疗营养素固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109170893A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939418A (zh) * | 2005-09-30 | 2007-04-04 | 张晓峰 | 一种食药同源的中草药组合物 |
| CN102091122A (zh) * | 2010-09-06 | 2011-06-15 | 山东好当家海洋发展股份有限公司 | 一种复方降压中药制剂及其制备方法 |
| CN104256008A (zh) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | 山楂决明子茶及其制备方法 |
| CN104799393A (zh) * | 2014-01-23 | 2015-07-29 | 河南省永传医药科技有限公司 | 一种葛根决明子固体饮料 |
-
2018
- 2018-09-29 CN CN201811149052.XA patent/CN109170893A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939418A (zh) * | 2005-09-30 | 2007-04-04 | 张晓峰 | 一种食药同源的中草药组合物 |
| CN102091122A (zh) * | 2010-09-06 | 2011-06-15 | 山东好当家海洋发展股份有限公司 | 一种复方降压中药制剂及其制备方法 |
| CN104799393A (zh) * | 2014-01-23 | 2015-07-29 | 河南省永传医药科技有限公司 | 一种葛根决明子固体饮料 |
| CN104256008A (zh) * | 2014-09-27 | 2015-01-07 | 山东吴氏恒康健康科技有限公司 | 山楂决明子茶及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 39健康网: "决明子，菊花，桑叶，葛根，山楂能不能一起泡水喝", 《HTTPS://WAPASK-MIP.39.NET/BDSSHZ/QUESTION/34194125.HTML》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102871175B (zh) | 一种润肺止咳营养饮料及其制备方法 | |
| CN102178314B (zh) | 一种辅助降血压功能的苦荞保健饮料及其生产工艺 | |
| CN103387899B (zh) | 一种红茶酒及其制造方法 | |
| CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
| CN106562428A (zh) | 一种美颜美体膏滋及其制备方法 | |
| CN105031517A (zh) | 一种降三高的铁皮石斛保健茶及其制备方法 | |
| CN101518595A (zh) | 具有降脂减肥、抗氧化功能的药物组合物及其制备方法 | |
| CN104207241B (zh) | 一种药食同源复合保健饮料及其制备方法 | |
| CN109123301A (zh) | 一种芦笋发酵固体饮料及其制备方法和应用 | |
| CN108887544A (zh) | 一种天然养生饮料 | |
| CN101385536A (zh) | 一种天然植物降糖泡腾饮料 | |
| CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
| CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
| CN102125632A (zh) | 防治高血压的中药保健茶 | |
| CN104388263A (zh) | 山楂桂圆养生中药酒及制备方法 | |
| CN109170893A (zh) | 用于高血压症的食疗营养素固体饮料及其制备方法 | |
| CN102188642A (zh) | 一种减肥健身保健酒及其制备方法 | |
| CN105796971A (zh) | 一种治疗脂肪肝的中药制剂及其制作方法 | |
| CN106551225A (zh) | 一种饮料及其制备方法 | |
| CN106804794A (zh) | 一种具有减肥降脂通便功效的保健茶 | |
| CN105410268A (zh) | 一种明目降脂的菟丝子保健茶及其制备方法 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
| CN109010518A (zh) | 降压茶及其制备方法和应用方法 | |
| CN109170052A (zh) | 一种石斛养胃保健茶及其制备方法 | |
| CN108159191A (zh) | 壮阳健肾的组合物、用途和口服液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190111 |
|
| RJ01 | Rejection of invention patent application after publication |